<Suppliers Price>

2-Methyl-6-nitrobenzoic anhydride

Names

[ CAS No. ]:
434935-69-0

[ Name ]:
2-Methyl-6-nitrobenzoic anhydride

[Synonym ]:
MNBA
6-Nitro-o-toluic Anhydride
2-Methyl-6-nitrobenzoic anhydride
MFCD06797117
(2-methyl-6-nitrobenzoyl) 2-methyl-6-nitrobenzoate

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
559.4±50.0 °C at 760 mmHg

[ Melting Point ]:
177ºC

[ Molecular Formula ]:
C16H12N2O7

[ Molecular Weight ]:
344.276

[ Flash Point ]:
246.5±32.1 °C

[ Exact Mass ]:
344.064453

[ PSA ]:
135.01000

[ LogP ]:
2.94

[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C

[ Index of Refraction ]:
1.623

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26-36

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2916399090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2916399090

[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.

Toxicol. Sci. 141(1) , 78-89, (2014)

In the present study, a previously established integrated testing strategy (ITS) for in vitro estrogenicity testing was extended with additional in vitro assays in order to broaden its sensitivity to ...

Improved profiling of estrogen metabolites by orbitrap LC/MS.

Steroids 99 , 84-90, (2015)

Estrogen metabolites are important biomarkers to evaluate cancer risks and metabolic diseases. Due to their low physiological levels, a sensitive and accurate method is required, especially for the qu...

Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer.

Steroids 92 , 39-44, (2014)

Although accumulating evidence indicates high expression of CYP17A1(P45017A1) allows castration resistant prostate cancer (CRPC) to maintain high intratumoral androgen levels, the potential P45017A1 a...


More Articles


Related Compounds